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To the editor: A recent surveillance and outbreak report 
published in Eurosurveillance by Petrovay et al. on the 
‘Emergence of the lymphogranuloma venereum L2c 
genovariant, Hungary, 2012 to 2016’ [1] provides an 
observation of the first European cases of a genotype 
of Chlamydia trachomatis associated with severe haem-
orrhagic proctitis. The authors of this paper diagnosed 
the strains as lymphogranuloma venereum (LGV)-
associated and performed partial sequencing of the 
ompA gene (ca 1,070 bp), which is a standard typing 
method for C. trachomatis. The ompA gene sequence 
obtained was compared with those from reference iso-
lates, and reported to be 100% concordant with the 
ompA sequence belonging to an L2-D recombinant 
strain described in 2011 [2]. This strain was named 
‘L2c’, as it was found to possess a chimeric genome, 
not because it has a novel ompA-genotype. We would 
like to point out that the ompA gene sequence of this 
L2-D recombinant strain, and by implication those of 
the Hungarian isolates, is identical to that of archetypal 
L2 strains, for example the reference strain L2/434 [3].
Petrovay et al. found that the pmpH-genotype of the 
Hungarian strains reflect that of an LGV strain, contain-
ing a diagnostic 36 bp deletion. Unfortunately this locus 
does not discriminate between L2 strains and L2-D. As 
the authors appear not to have checked for concord-
ance between their strains and the L2-D recombinant 
strain in other genomic loci, it is not possible to deter-
mine whether the strains reflect the appearance of this 
L2-D recombinant, or rather a circulating L2 LGV strain. 
Thus, it is premature to assume that these Hungarian 
LGV strains reflect the presence of the ‘hypervirulent’ 
L2-D recombinant strain, despite the described clinical 
symptoms. We find it more likely that the authors have 
observed a resurgence in cases with ompA-genotype 
L2, as described last year [4].
For the Chlamydia community, it is important to rec-
ognise that the use of the term ‘L2c genotype’ in the 
case of the L2-D recombinant strain is a misnomer, as 
the ompA-genotype of this strain is an archetypal L2. 
This nomenclature was also the source of confusion in 
a recent paper from Slovenia describing the presence 
of ‘L2c’ [5], again with further analysis now showing 
that the ompA-genotype of this strain is also identical 
to L2. The distinct L2c ompA-genotype was described 
in a 2008 publication, and has 2 nucleotide differences 
to that of L2 [6].
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Given the high level of recombination observed in C. 
trachomatis [7], typing techniques based on a few 
loci can never give a full indication of the underlying 
genomic background: only whole genome sequenc-
ing and detailed phylogenetic analysis can provide 
this. Therefore we would recommend that future pub-
lications are absolutely clear as to which genotyp-
ing method they have used in strain descriptions, for 
example a common target such as the ompA-genotype. 
Furthermore, Chlamydia researchers should be aware 
of this awkwardness of nomenclature, should thor-
oughly compare their ompA sequences against a data-
base of known L2 ompA-genotypes (L2: AM884176; 
L2a: AB915594, L2b: AM884177; L2c: EF460796; 
L2d: EF460797; L2e: EF460798; L2f: EU676181; L2g: 
EU676180; L2bV1: JX971936; L2bV2: KU518893; L2bV3: 
KU518894; L2bV4: KU518892) [3,6,8-10], and report 
their findings more fully.
As it stands, the description of the Hungarian strains as 
‘L2c’ is inaccurate in the sense of the ompA-genotype. 
Importantly, it is not possible to make any conclusions 
about the European appearance of this ‘hypervirulent’ 
L2-D recombinant strain without further sequenc-
ing of additional genomic loci, ideally whole genome 
sequencing, or investigations into in vitro phenotypes.
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